Leyao Wang, PhD, MPH awarded MISA Global Incubator Seed Grant (Links to an external site)
Leyao Wang, PhD, MPH, Instructor in Medicine, has been awarded a Global Incubator Seed Grant from the McDonnell International Scholars Academy at Washington University in St Louis to support the initiation of a collaboration between her lab and two clinical departments at Ghana Medical Center to study the infant nasal microbiome in Ghana.
Ofer Zimmerman, MD to begin collaborative Allergy and Immunology clinic with Infectious Disease
Ofer Zimmerman, MD, Allergist and Immunologist and Instructor in Medicine, will begin a collaborative clinic with Infectious Disease at 620 South Taylor Ave., Suite 100 beginning August 31, 2021. This collaborative clinic will focus on patients with immunological disorders, including: recurrent infections, recurrent pneumonia, mycobacterial infections (lung or invasive), low antibody levels, immunodeficiency, and autoimmunity. […]
Dr. Ver Heul participates in neuroimmunology research published in The Annual Review of Immunology (Links to an external site)
Dr. Ver Heul’s latest research is in the burgeoning field of neuroimmunology. It is increasingly recognized that the immune system and nervous system cooperate to maintain health and that a breakdown in this cooperation underlies many chronic inflammatory diseases. In this review, Dr. Ver Heul and colleagues summarize the cutting edge of this field focusing […]
Dr. Ver Heul participates in Crohn’s disease research published in Science (Links to an external site)
Dr. Ver Heul is a key contributor on a team seeking to understand how healing and inflammation become dysregulated in inflammatory bowel disease. The team recently found that a fungus found in many foods like cheese and meat can colonize injured intestinal tissue in patients with Crohn’s Disease, which impairs healing and leads to more […]
Dr. Leyao Wang receives grant to further COVID-19 research
Leyao Wang, PhD, MPH has received a grant from The Center for Diabetes Translation Research to help fund the study of factors underlying increased risks of COVID-19 infection and severe outcomes among people with diabetes.


